News & Perspective

Dec 16, 2002

Dec 16, 2002

Half of second target group for smallpox shots may refuse them, officials estimate

(CIDRAP News) – Federal health officials project that about half of the estimated 10 million health and emergency response workers targeted for the second round of smallpox vaccinations will refuse the shots.

Nov 26, 2002

Nov 26, 2002

Study to check smallpox immunity in people inoculated decades ago

(CIDRAP News) – About 900 adults who received smallpox shots in childhood are being revaccinated in a multicenter study to determine whether they still have any immunity to smallpox.

Nov 14, 2002

Nov 14, 2002

HHS to study whether chronic wasting disease threatens humans

Editor's note: This story was updated Nov 15 to include additional information from Food and Drug Administration officials.

(CIDRAP News) – Federal health officials have announced plans to expand research on whether chronic wasting disease (CWD) in deer and elk poses a threat to humans and other species.

Jun 28, 2002

Jun 28, 2002

Trial of Aventis smallpox vaccine getting under way

(CIDRAP News) – A clinical trial of the decades-old supply of smallpox vaccine held by Aventis Pasteur is in progress, and early signs are that the vaccine is still potent, according to a spokesman for the National Institute of Allergy and Infectious Diseases (NIAID).

Mar 29, 2002

Mar 29, 2002

NIAID study: Diluted smallpox vaccine remains potent

A study indicates that the existing smallpox vaccine remains effective after being diluted five-fold and ten-fold, suggesting that the 15-million dose US stockpile can be stretched much further.

Mar 18, 2002

Mar 18, 2002

NIAID releases lengthy bioterrorism research agenda

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has released a 68-page report on its plan for expanding research on "Category A" bioterrorism agents: anthrax, smallpox, plague, tularemia, viral hemorrhagic fevers, and botulism.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»